The DOI matches its Crossref record; 543 of the 543 references it cites were found in a registry or an index.
The wound healing, chronic fibrosis, and cancer progression triad
Open accessAbstract
For decades tumors have been recognized as “wounds that do not heal.” Besides the commonalities that tumors and wounded tissues share, the process of wound healing also portrays similar characteristics with chronic fibrosis. In this review, we suggest a tight interrelationship, which is governed as a concurrence of cellular and microenvironmental reactivity among wound healing, chronic fibrosis, and cancer development/progression (i.e., the WHFC triad). It is clear that the same cell types, as well as soluble and matrix elements that drive wound healing (including regeneration) via distinct signaling pathways, also fuel chronic fibrosis and tumor progression. Hence, here we review the relationship between fibrosis and cancer through the lens of wound healing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 201–400 of 543
Targeting the HGF/Met signaling pathway in cancer therapy
Cecchi, F., Rabe, D. C., & Bottaro, D. P. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2012.680957 · Cited by 222
Human breast carcinoma desmoplasia is PDGF initiated
Shao, Z.-M., Nguyen, M., & Barsky, S. H. (2000) · Oncogene · doi:10.1038/sj.onc.1203785 · Cited by 221
The biological role and regulation of versican levels in cancer
Ricciardelli, C., Sakko, A. J., Ween, M. P., Russell, D. L., & Horsfall, D. J. (2009) · Cancer and Metastasis Reviews · doi:10.1007/s10555-009-9182-y · Cited by 220
Koukourakis, M. I., Giatromanolaki, A. N., Brekken, R. A., Sivridis, E., Gatter, K. C., Harris, A. L., & Sage, E. H. (2003) · PubMed · Cited by 220
Natural Killer Cells in Human Cancer: From Biological Functions to Clinical Applications
Levy, E. M., Roberti, M. P., & Mordoh, J. (2011) · BioMed Research International · doi:10.1155/2011/676198 · Cited by 219
Elevated Hyaluronan Production Induces Mesenchymal and Transformed Properties in Epithelial Cells
Zoltan-Jones, A., Huang, L., Ghatak, S., & Toole, B. P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308168200 · Cited by 219
Howell, D. C. J., Johns, R. H., Lasky, J. A., Shan, B., Scotton, C. J., Laurent, G. J., & Chambers, R. C. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62354-1 · Cited by 218
Cufí, S., Vazquez-Martin, A., Oliveras-Ferraros, C., Martin-Castillo, B., Joven, J., & Menendez, J. A. (2010) · Cell Cycle · doi:10.4161/cc.9.22.14048 · Cited by 216
Zeremski, M., Petrovic, L. M., Chiriboga, L., Brown, Q. B., Yee, H. T., Kinkhabwala, M., Jacobson, I. M., Dimova, R., Markatou, M., & Talal, A. H. (2008) · Hepatology · doi:10.1002/hep.22500 · Cited by 216
CXCR2 antagonists for the treatment of pulmonary disease
Chapman, R. W., Phillips, J. E., Hipkin, R. W., Curran, A. K., Lundell, D., & Fine, J. S. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.10.005 · Cited by 214
The Insulin-Like Growth Factor System in Cancer
Weroha, S. J., & Haluska, P. (2012) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2012.04.014 · Cited by 213
Fibroblast surface antigen: A new serum protein
Ruoslahti, E., Vaheri, A., Kuusela, P., & Linder, E. (1973) · Biochimica et Biophysica Acta (BBA) - Protein Structure · doi:10.1016/0005-2795(73)90310-3 · Cited by 211
Milam, J. E., Keshamouni, V. G., Phan, S. H., Hu, B., Gangireddy, S. R., Hogaboam, C. M., Standiford, T. J., Thannickal, V. J., & Reddy, R. C. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00333.2007 · Cited by 211
Hedgehog-Gli Pathway Activation during Kidney Fibrosis
Fabian, S. L., Penchev, R. R., St-Jacques, B., Rao, A. N., Sipilä, P., West, K. A., McMahon, A. P., & Humphreys, B. D. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.12.039 · Cited by 205
Lysyl Oxidase–Like 2 as a New Poor Prognosis Marker of Squamous Cell Carcinomas
Peinado, H., Moreno-Bueno, G., Hardisson, D., Pérez-Gómez, E., Santos, V., Mendiola, M., de Diego, J. I., Nistal, M., Quintanilla, M., Portillo, F., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6345 · Cited by 205
PPAR-γ agonist attenuates renal interstitial fibrosis and inflammation through reduction of TGF-β
Kawai, T., Masaki, T., Doi, S., Arakawa, T., Yokoyama, Y., Doi, T., Kohno, N., & Yorioka, N. (2009) · Laboratory Investigation · doi:10.1038/labinvest.2008.104 · Cited by 203
Diabetes, cancer, and metformin: connections of metabolism and cell proliferation
Gallagher, E. J., & LeRoith, D. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06285.x · Cited by 202
Okuda, H., Kobayashi, A., Xia, B., Watabe, M., Pai, S. K., Hirota, S., Xing, F., Liu, W., Pandey, P. R., Fukuda, K., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-1678 · Cited by 201
Paracrine Hedgehog Signaling in Cancer
Theunissen, J.-W., & de Sauvage, F. J. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0756 · Cited by 201
Buijs, J. T., Rentsch, C. A., van der Horst, G., van Overveld, P. G. M., Wetterwald, A., Schwaninger, R., Henriquez, N. V., ten Dijke, P., Borovecki, F., Markwalder, R., et al. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070168 · Cited by 200
Yang, J., Shultz, R. W., Mars, W. M., Wegner, R. E., Li, Y., Dai, C., Nejak, K., & Liu, Y. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0216219 · Cited by 200
TGF-β-induced epithelial-mesenchymal transition: A link between cancer and inflammation
Fuxe, J., & Karlsson, M. C. I. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.05.004 · Cited by 198
Sonic Hedgehog Signaling Mediates Epithelial–Mesenchymal Communication and Promotes Renal Fibrosis
Ding, H., Zhou, D., Hao, S., Zhou, L., He, W., Nie, J., Hou, F. F., & Liu, Y. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011060614 · Cited by 198
Sonnylal, S., Shi‐Wen, X., Leoni, P., Naff, K., Van Pelt, C. S., Nakamura, H., Leask, A., Abraham, D., Bou‐Gharios, G., & de Crombrugghe, B. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27382 · Cited by 196
Molecular Pathways: Targeting the TGF-β Pathway for Cancer Therapy
Smith, A. L., Robin, T. P., & Ford, H. L. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3224 · Cited by 193
Inhibition of focal adhesion kinase prevents experimental lung fibrosis and myofibroblast formation
Lagares, D., Busnadiego, O., García‐Fernández, R. A., Kapoor, M., Liu, S., Carter, D. E., Abraham, D., Shi‐Wen, X., Carreira, P., Fontaine, B. A., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.33482 · Cited by 192
Lokeshwar, V. B., Lopez, L. E., Munoz, D., Chi, A., Shirodkar, S. P., Lokeshwar, S. D., Escudero, D. O., Dhir, N., & Altman, N. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3185 · Cited by 191
Hypoxia and Hypoxia Signaling in Tissue Repair and Fibrosis
(2012) · International Review of Cell and Molecular Biology · doi:10.1016/b978-0-12-394307-1.00003-5 · Cited by 190
Kulkarni, A. A., Thatcher, T. H., Olsen, K. C., Maggirwar, S. B., Phipps, R. P., & Sime, P. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015909 · Cited by 189
TGF-beta Signaling in Cancer Treatment
Fabregat, I., Fernando, J., Mainez, J., & Sancho, P. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990591 · Cited by 187
Thakkar, B., Aronis, K. N., Vamvini, M. T., Shields, K., & Mantzoros, C. S. (2013) · Metabolism · doi:10.1016/j.metabol.2013.01.014 · Cited by 186
Williams, E. J., Benyon, R. C., Trim, N., Hadwin, R., Grove, B. H., Arthur, M. J. P., Unemori, E. N., & Iredale, J. P. (2001) · Gut · doi:10.1136/gut.49.4.577 · Cited by 186
Yang, J., Dai, C., & Liu, Y. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2003090795 · Cited by 186
Chin, Y. R., & Toker, A. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.02.031 · Cited by 184
Strutz, F., Zeisberg, M., Hemmerlein, B., Sattler, B., Hummel, K., Becker, V., & Müller, G. A. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00997.x · Cited by 183
Matrix Elasticity, Cytoskeletal Tension, and TGF-β: The Insoluble and Soluble Meet
Wells, R. G., & Discher, D. E. (2008) · Science Signaling · doi:10.1126/stke.110pe13 · Cited by 183
Khalil, N., Xu, Y. D., O'Connor, R., & Duronio, V. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m510441200 · Cited by 182
Chaturvedi, P., Gilkes, D. M., Wong, C. C. L., Kshitiz, K., Luo, W., Zhang, H., Wei, H., Takano, N., Schito, L., Levchenko, A., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci69244 · Cited by 181
Role of the VEGF/VEGFR Axis in Cancer Biology and Therapy
(2012) · Advances in Cancer Research · doi:10.1016/b978-0-12-386503-8.00006-5 · Cited by 180
Wang, H., Haeger, S. M., Kloxin, A. M., Leinwand, L. A., & Anseth, K. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039969 · Cited by 179
Role of the SDF-1/CXCR4 Axis in the Pathogenesis of Lung Injury and Fibrosis
Xu, J., Mora, A., Shim, H., Stecenko, A., Brigham, K. L., & Rojas, M. (2007) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2006-0187oc · Cited by 179
Factor Xa: at the crossroads between coagulation and signaling in physiology and disease
Borensztajn, K., Peppelenbosch, M. P., & Spek, C. A. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2008.08.001 · Cited by 179
Phanish, M. K., Winn, S. K., & Dockrell, M. E. C. (2009) · Nephron Experimental Nephrology · doi:10.1159/000262316 · Cited by 179
Decorin–TGFβ Axis in Hepatic Fibrosis and Cirrhosis
Baghy, K., Iozzo, R. V., & Kovalszky, I. (2012) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155412438104 · Cited by 178
PAI‐1, progress in understanding the clinical problem and its aetiology
Iwaki, T., Urano, T., & Umemura, K. (2012) · British Journal of Haematology · doi:10.1111/j.1365-2141.2012.09074.x · Cited by 177
Choi, S. S., Syn, W.-K., Karaca, G. F., Omenetti, A., Moylan, C. A., Witek, R. P., Agboola, K. M., Jung, Y., Michelotti, G. A., & Diehl, A. M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.168542 · Cited by 174
Liu, Y., Cai, S., Shu, X. Z., Shelby, J., & Prestwich, G. D. (2007) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2007.00211.x · Cited by 174
White, E. S., & Muro, A. F. (2011) · IUBMB Life · doi:10.1002/iub.493 · Cited by 174
Schneider, M., Hansen, J. L., & Sheikh, S. P. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-007-0301-3 · Cited by 173
Fibrosis: recent advances in myofibroblast biology and new therapeutic perspectives
Hinz, B., & Gabbiani, G. (2010) · F1000 Biology Reports · doi:10.3410/b2-78 · Cited by 172
Walter, K., Omura, N., Hong, S.-M., Griffith, M., Vincent, A., Borges, M., & Goggins, M. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1913 · Cited by 172
Genetic or Pharmacologic Blockade of EGFR Inhibits Renal Fibrosis
Liu, N., Guo, J.-K., Pang, M., Tolbert, E., Ponnusamy, M., Gong, R., Bayliss, G., Dworkin, L. D., Yan, H., & Zhuang, S. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011050493 · Cited by 170
Focal adhesion kinase and tumour angiogenesis
Lechertier, T., & Hodivala‐Dilke, K. (2012) · The Journal of Pathology · doi:10.1002/path.3018 · Cited by 169
Lipponen, P., Aaltomaa, S., Tammi, R., Tammi, M., Ågren, U., & Kosma, V.-M. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00448-2 · Cited by 168
Johnson, N. R., & Wang, Y. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.11.004 · Cited by 168
Schwager, K., Kaspar, M., Bootz, F., Marcolongo, R., Paresce, E., Neri, D., & Trachsel, E. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2814 · Cited by 167
Pirinen, R. T., Tammi, R., Tammi, M., Hirvikoski, P. P., Parkkinen, J. J., Johansson, R. T., B�hm, J. P., Hollm�n, S., & Kosma, V. (2001) · International Journal of Cancer · doi:10.1002/1097-0215(20010120)95:1<12::aid-ijc1002>3.0.co;2-e · Cited by 166
Involvement of Notch Signaling in Wound Healing
Chigurupati, S., Arumugam, T. V., Son, T. G., Lathia, J. D., Jameel, S., Mughal, M. R., Tang, S., Jo, D., Camandola, S., Giunta, M., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001167 · Cited by 165
Anti-cancer properties of low-molecular-weight heparin: Preclinical evidence
Petersen, L., & Mousa, S. (2009) · Thrombosis and Haemostasis · doi:10.1160/th08-12-0832 · Cited by 165
Shariat, S. F., Kattan, M. W., Traxel, E., Andrews, B., Zhu, K., Wheeler, T. M., & Slawin, K. M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0768-03 · Cited by 165
ErbB/EGF Signaling and EMT in Mammary Development and Breast Cancer
Hardy, K. M., Booth, B. W., Hendrix, M. J. C., Salomon, D. S., & Strizzi, L. (2010) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-010-9172-2 · Cited by 164
Shi‐wen, X., Kennedy, L., Renzoni, E. A., Bou‐Gharios, G., du Bois, R. M., Black, C. M., Denton, C. P., Abraham, D. J., & Leask, A. (2007) · Arthritis & Rheumatism · doi:10.1002/art.23134 · Cited by 163
SPARC-null Mice Exhibit Accelerated Cutaneous Wound Closure
Bradshaw, A. D., Reed, M. J., & Sage, E. H. (2002) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540205000101 · Cited by 163
Tissue factor and cell signalling in cancer progression and thrombosis
RUF, W., DISSE, J., CARNEIRO‐LOBO, T. C., YOKOTA, N., & SCHAFFNER, F. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04318.x · Cited by 162
The benefits and challenges associated with the use of drug delivery systems in cancer therapy
Cukierman, E., & Khan, D. R. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.04.020 · Cited by 162
Self-citationSakuma, K., Aoki, M., & Kannagi, R. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1111135109 · Cited by 162
Τσούπρας, Α., Iatrou, C., Frangia, C., & Demopoulos, C. A. (2009) · Infectious Disorders - Drug Targets · doi:10.2174/187152609788922555 · Cited by 161
Role of Sonic Hedgehog in idiopathic pulmonary fibrosis
Bolaños, A. L., Milla, C. M., Lira, J. C., Ramírez, R., Checa, M., Barrera, L., García-Alvarez, J., Carbajal, V., Becerril, C., Gaxiola, M., et al. (2012) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00184.2012 · Cited by 160
Hedgehog signaling controls fibroblast activation and tissue fibrosis in systemic sclerosis
Horn, A., Palumbo, K., Cordazzo, C., Dees, C., Akhmetshina, A., Tomcik, M., Zerr, P., Avouac, J., Gusinde, J., Zwerina, J., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34444 · Cited by 160
Schaefer, L., Macakova, K., Raslik, I., Micegova, M., Gröne, H.-J., Schönherr, E., Robenek, H., Echtermeyer, F. G., Grässel, S., Bruckner, P., et al. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64937-1 · Cited by 160
Leins, A., Riva, P., Lindstedt, R., Davidoff, M. S., Mehraein, P., & Weis, S. (2003) · Cancer · doi:10.1002/cncr.11796 · Cited by 160
De Wever, O., Westbroek, W., Verloes, A., Bloemen, N., Bracke, M., Gespach, C., Bruyneel, E., & Mareel, M. (2004) · Journal of Cell Science · doi:10.1242/jcs.01322 · Cited by 160
Madala, S. K., Schmidt, S., Davidson, C. R., Ikegami, M., Wert, S. E., & Hardie, W. D. (2011) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2011-0237oc · Cited by 159
Modulation of matrix remodeling by SPARC in neoplastic progression
Chlenski, A., & Cohn, S. L. (2009) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2009.11.018 · Cited by 159
Diabetes and pancreatic cancer
Cui, Y., & Andersen, D. K. (2012) · Endocrine-Related Cancer · doi:10.1530/erc-12-0105 · Cited by 159
Bjermer, L. H., Lundgren, R., & Hällgren, R. (1989) · Thorax · doi:10.1136/thx.44.2.126 · Cited by 158
Rhodes, L. V., Short, S. P., Neel, N. F., Salvo, V. A., Zhu, Y., Elliott, S., Wei, Y., Yu, D., Sun, M., Muir, S. E., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-3185 · Cited by 154
Periostin modulates myofibroblast differentiation during full-thickness cutaneous wound repair
Elliott, C. G., Wang, J., Guo, X., Shiwen, X., Eastwood, M., Guan, J., Leask, A., Conway, S. J., & Hamilton, D. W. (2012) · Journal of Cell Science · doi:10.1242/jcs.087841 · Cited by 152
Prostaglandin E2 and the Pathogenesis of Pulmonary Fibrosis
Bozyk, P. D., & Moore, B. B. (2011) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2011-0025rt · Cited by 152
Imokawa, S., Sato, A., Hayakawa, H., KOTANI, M., Urano, T., & Takada, A. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.156.2.9608094 · Cited by 151
Utispan, K., Thuwajit, P., Abiko, Y., Charngkaew, K., Paupairoj, A., Chau‐in, S., & Thuwajit, C. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-13 · Cited by 151
Masamune, A., Kikuta, K., Satoh, M., Sakai, Y., Satoh, A., & Shimosegawa, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107582200 · Cited by 150
Cao, Y., Guangqi, E., Wang, E., Pal, K., Dutta, S. K., Bar‐Sagi, D., & Mukhopadhyay, D. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-4058 · Cited by 150
Aoyagi, K., Maeno, T., Matsui, H., Ueno, M., Hara, K., Aoki, Y., Aoki, F., Shimizu, T., Doi, H., Kawai‐Kowase, K., et al. (2011) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2010-0140oc · Cited by 149
TGF-β Receptor II Loss Promotes Mammary Carcinoma Progression by Th17-Dependent Mechanisms
Novitskiy, S. V., Pickup, M. W., Gorska, A. E., Owens, P., Chytil, A., Aakre, M. E., Wu, H., Shyr, Y., & Moses, H. L. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0100 · Cited by 149
Uhal, B. D., Kim, J. K., Li, X., & Molina‐Molina, M. (2007) · Current Pharmaceutical Design · doi:10.2174/138161207780618885 · Cited by 147
Physico-mechanical aspects of extracellular matrix influences on tumorigenic behaviors
Cukierman, E., & Bassi, D. (2010) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2010.04.004 · Cited by 146
Self-citationSaid, N. A., Sänchez‐Carbayo, M., Smith, S. C., & Theodorescu, D. (2012) · Journal of Clinical Investigation · doi:10.1172/jci61392 · Cited by 145
Moulin, V., Larochelle, S., Langlois, C., Thibault, I., Lopez‐Vallé, C. A., & Roy, M. (2004) · Journal of Cellular Physiology · doi:10.1002/jcp.10415 · Cited by 144
IL-6 Secretion by Human Pancreatic Periacinar Myofibroblasts in Response to Inflammatory Mediators
Shimada, M., Andoh, A., Hata, K., Tasaki, K., Araki, Y., Fujiyama, Y., & Bamba, T. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.2.861 · Cited by 144
Urakawa, H., Nishida, Y., Wasa, J., Arai, E., Zhuo, L., Kimata, K., Kozawa, E., Futamura, N., & Ishiguro, N. (2011) · International Journal of Cancer · doi:10.1002/ijc.26014 · Cited by 144
Hepatocyte Growth Factor Inhibits Epithelial to Myofibroblast Transition in Lung Cells via Smad7
Shukla, M. N., Rose, J. L., Ray, R., Lathrop, K. L., Ray, A., & Ray, P. (2008) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2008-0217oc · Cited by 143
Efficient TGFβ-induced epithelial–mesenchymal transition depends on hyaluronan synthase HAS2
Porsch, H., Bernert, B., Mehić, M., Theocharis, A. D., Heldin, C., & Heldin, P. (2012) · Oncogene · doi:10.1038/onc.2012.475 · Cited by 143
Reka, A. K., Kurapati, H., Narala, V. R., Bommer, G. T., Chen, J., Standiford, T. J., & Keshamouni, V. G. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0570 · Cited by 143
Bussolati, B., Biancone, L., Cassoni, P., Russo, S., Rola‐Pleszczynski, M., Montrucchio, G., & Camussi, G. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64808-0 · Cited by 140
Ziegenhagen, M. W., Zabel, P., Zissel, G., Schlaak, M. S., & Müller–Quernheim, J. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.3.9705014 · Cited by 139
Stiff Collagen Matrices Increase Tumorigenic Prolactin Signaling in Breast Cancer Cells
Barcus, C. E., Keely, P. J., Eliceiri, K. W., & Schuler, L. A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.447631 · Cited by 139
Singh, A. P., Arora, S., Bhardwaj, A., Srivastava, S. K., Kadakia, M., Wang, B., Grizzle, W. E., Owen, L. B., & Singh, S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.409581 · Cited by 139
Tissue Factor and PAR2 Signaling in the Tumor Microenvironment
Schaffner, F., & Ruf, W. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.177428 · Cited by 139
The role of CXCR3 and CXCR4 in colorectal cancer metastasis
Murakami, T., Kawada, K., Iwamoto, M., Akagami, M., Hida, K., Nakanishi, Y., Kanda, K., Kawada, M., Seno, H., Taketo, M. M., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.27670 · Cited by 139
IL-6 Modulates Alpha-Smooth Muscle Actin Expression in Dermal Fibroblasts from IL-6-Deficient Mice
Gallucci, R. M., Lee, E. G., & Tomasek, J. J. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700109 · Cited by 138
Maihöfner, C., Charalambous, M. P., Bhambra, U., Lightfoot, T., Geisslinger, G., & Gooderham, N. J. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg006 · Cited by 138
FGF-1 reverts epithelial-mesenchymal transition induced by TGF-β1 through MAPK/ERK kinase pathway
Ramos, C., Becerril, C., Montaño, M., de Alba, C. G., Ramírez, R., Checa, M., Pardo, A., & Selman, M. (2010) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00070.2010 · Cited by 137
Hancox, R. A., Allen, M. D., Holliday, D. L., Edwards, D. R., Pennington, C. J., Guttery, D. S., Shaw, J., Walker, R. A., Pringle, J. H., & Jones, J. L. (2009) · Breast Cancer Research · doi:10.1186/bcr2251 · Cited by 136
Webber, J. P., Meran, S., Steadman, R., & Phillips, A. O. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806989200 · Cited by 136
Yamada, K. M., Olden, K., & Pastan, I. H. (1978) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1978.tb16807.x · Cited by 135
Periostin as a Heterofunctional Regulator of Cardiac Development and Disease
Conway, S. J., & Molkentin, J. D. (2008) · Current Genomics · doi:10.2174/138920208786847917 · Cited by 134
Préaux, A.-M., Mallat, A., Nhieu, J. T. V., d’Ortho, M., Hembry, R. M., & Mavier, P. (1999) · Hepatology · doi:10.1002/hep.510300432 · Cited by 134
Role of Versican, Hyaluronan and CD44 in Ovarian Cancer Metastasis
Ween, M. P., Oehler, M. K., & Ricciardelli, C. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12021009 · Cited by 133
Plasma Fibrinogen Levels and Prognosis in Patients with Ovarian Cancer: A Multicenter Study
Polterauer, S., Grimm, C., Seebacher, V., Concin, N., Marth, C., Tomovski, C., Husslein, H., Leipold, H., Hefler‐Frischmuth, K., Tempfer, C., et al. (2009) · The Oncologist · doi:10.1634/theoncologist.2009-0079 · Cited by 133
Inoue, Y., King, T. E., Barker, E. P., Daniloff, E., & Newman, L. S. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2010014 · Cited by 130
Zaja‐Milatovic, S., & Richmond, A. J. (2008) · PubMed · doi:10.14670/hh-23.1399 · Cited by 129
A hyaluronan synthase suppressor, 4‐methylumbelliferone, inhibits liver metastasis of melanoma cells
Yoshihara, S., Kon, A., Kudo, D., Nakazawa, H., Kakizaki, I., Sasaki, M., Endo, M., & Takagaki, K. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.03.079 · Cited by 129
Prajapati, R. T., Chavally‐Mis, B., Herbage, D., Eastwood, M., & Brown, R. A. (2000) · Wound Repair and Regeneration · doi:10.1046/j.1524-475x.2000.00226.x · Cited by 129
Xu, X. M., Zhu, F., Zhang, M., Zeng, D., Luo, D., Liu, G., Cui, W., Wang, S., Guo, W., Xing, W., et al. (2012) · Cells Tissues Organs · doi:10.1159/000342921 · Cited by 128
Tyrosine kinase signaling in fibrotic disorders
Beyer, C., & Distler, J. H. W. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.06.008 · Cited by 127
Modulation of TGFβ1-Dependent Myofibroblast Differentiation by Hyaluronan
Webber, J. P., Jenkins, R. L., Meran, S., Phillips, A. O., & Steadman, R. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080837 · Cited by 127
Relaxin Promotes Prostate Cancer Progression
Feng, S., Agoulnik, I. U., Bogatcheva, N. V., Kamat, A. A., Kwabi‐Addo, B., Li, R., Ayala, G., Ittmann, M., & Agoulnik, A. I. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2492 · Cited by 127
Inhibition of Integrin-Linked Kinase Attenuates Renal Interstitial Fibrosis
Li, Y., Tan, X., Dai, C., Stolz, D. B., Wang, D., & Liu, Y. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008090930 · Cited by 126
The myofibroblast and its tumours
Eyden, B. P., Banerjee, S. S., Shenjere, P., & Fisher, C. (2008) · Journal of Clinical Pathology · doi:10.1136/jcp.2008.061630 · Cited by 125
Heinrich, E. L., Lee, W., Lu, J., Lowy, A. M., & Kim, J. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-68 · Cited by 125
Periostin Is Expressed in Pericryptal Fibroblasts and Cancer-associated Fibroblasts in the Colon
Kikuchi, Y., Kashima, T. G., Nishiyama, T., Shimazu, K., Morishita, Y., Shimazaki, M., Kii, I., Horie, H., Nagai, H., Kudō, A., et al. (2008) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.2008.951061 · Cited by 125
Deficiency of tenascin‐C attenuates liver fibrosis in immune‐mediated chronic hepatitis in mice
El-Karef, A., Yoshida, T., Gabazza, E. C., Nishioka, T., Inada, H., Sakakura, T., & Imanaka‐Yoshida, K. (2006) · The Journal of Pathology · doi:10.1002/path.2099 · Cited by 124
Diaz, V. M., Hurtado, M., Thomson, T. M., et al. (2004) · Gut · doi:10.1136/gut.2003.026831 · Cited by 124
PPAR‐γAgonists and Their Effects on IGF‐I Receptor Signaling: Implications for Cancer
Belfiore, A., Genua, M., & Malaguarnera, R. (2009) · PPAR Research · doi:10.1155/2009/830501 · Cited by 123
Crosstalk between TGF‐β and hedgehog signaling in cancer
Javelaud, D., Pierrat, M., & Mauviel, A. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.05.011 · Cited by 122
Yamaguchi, Y., Ono, J., 増岡, 美., Ohta, S., Izuhara, K., Ikezawa, Z., Aihara, M., & Takahashi, K. (2012) · British Journal of Dermatology · doi:10.1111/bjd.12117 · Cited by 122
Vial, C., Gutiérrez, J., Santander, C., Cabrera, D., & Brandan, E. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.189365 · Cited by 121
Target-seeking antifibrotic compound enhances wound healing and suppresses scar formation in mice
Järvinen, T. A. H., & Ruoslahti, E. I. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016233107 · Cited by 121
Crucial Role of Interleukin-4 in the Survival of Colon Cancer Stem Cells
Francipane, M. G., Alea, M. P., Lombardo, Y., Todaro, M., Medema, J. P., & Stassi, G. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6874 · Cited by 120
Michaylira, C. Z., Wong, G. S., Miller, C. G., Gutierrez, C. M., Nakagawa, H., Hammond, R., Klein-Szanto, A. J., Lee, J.-S., Kim, S. B., Herlyn, M., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0704 · Cited by 117
Zhou, H., Wang, J., Elliott, C. G., Wen, W., Hamilton, D. W., & Conway, S. J. (2010) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-010-0090-2 · Cited by 116
Angiotensin II Facilitates Breast Cancer Cell Migration and Metastasis
Rodrigues, S., Abdelkarim, M., Dillenburg-Pilla, P., Luissint, A., Tommaso, A. D., Deshayes, F., Pontes, C. L. S., Molina, A., Cagnard, N., Letourneur, F., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035667 · Cited by 115
Fang, F., Liu, L., Yang, Y., Tamaki, Z., Wei, J., Marangoni, R. G., Bhattacharyya, S., Summer, R. S., Ye, B., & Varga, J. (2012) · Arthritis Research & Therapy · doi:10.1186/ar4070 · Cited by 114
Hedgehog signaling is essential for normal wound healing
Le, H., Kleinerman, R., Lerman, O. Z., Brown, D., Galiano, R. D., Gurtner, G. C., Warren, S. M., Levine, J. P., & Saadeh, P. B. (2008) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2008.00430.x · Cited by 113
Blanc‐Brude, O., Archer, F., Leoni, P., et al. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.10.021 · Cited by 113
The role of focal adhesion kinase in tumor initiation and progression
Provenzano, P. P., & Keely, P. J. (2009) · Cell Adhesion & Migration · doi:10.4161/cam.3.4.9458 · Cited by 113
Faouzi, S., Bail, B. L., Neaud, V., Boussarie, L., Saric, J., Bioulac‐Sage, P., Balabaud, C. P., & Rosenbaum, J. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80074-9 · Cited by 112
Impaired wound healing in mice deficient in a matricellular protein SPARC (osteonectin, BM-40)
Basu, A., Kligman, L. H., Samulewicz, S., & Howe, C. C. (2001) · BMC Cell Biology · doi:10.1186/1471-2121-2-15 · Cited by 111
Castelló-Cros, R., Khan, D. R., Simons, J., Valianou, M., & Cukierman, E. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-94 · Cited by 110
Self-citationFibrinogen, acting as a mitogen for tubulointerstitial fibroblasts, promotes renal fibrosis
Sörensen, I., Susnik, N., Inhester, T., Degen, J. L., Melk, A., Haller, H., & Schmitt, R. (2011) · Kidney International · doi:10.1038/ki.2011.214 · Cited by 109
Coagulation cascade proteases and tissue fibrosis
Chambers, R. C., & Laurent, G. J. (2001) · Biochemical Society Transactions · doi:10.1042/bst0300194 · Cited by 108
TGF-β and BMP7 interactions in tumour progression and bone metastasis
Buijs, J. T., Henriquez, N. V., van Overveld, P. G. M., van der Horst, G., ten Dijke, P., & van der Pluijm, G. (2007) · Clinical & Experimental Metastasis · doi:10.1007/s10585-007-9118-2 · Cited by 107
Wynes, M. W., Frankel, S. K., & Riches, D. W. H. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0504288 · Cited by 107
Tissue Factor and Fibrin in Tumor Angiogenesis
Fernández, P. M., Patierno, S. R., & Rickles, F. R. (2004) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2004-822969 · Cited by 107
Boeck, A. D., Hendrix, A., Maynard, D., Bockstal, M. V., Daniëls, A., Pauwels, P., Gespach, C. P., Bracke, M., & Wever, O. D. (2012) · PROTEOMICS · doi:10.1002/pmic.201200179 · Cited by 106
Tenascin-C deficiency attenuates TGF-β-mediated fibrosis following murine lung injury
Carey, W. A., Taylor, G. D., Dean, W. B., & Bristow, J. D. (2010) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00385.2009 · Cited by 106
Tenascin-C promotes melanoma progression by maintaining the ABCB5-positive side population
Fukunaga‐Kalabis, M., Martinez, G., Nguyen, T. K., Kim, D., Santiago-Walker, A., Roesch, A., & Herlyn, M. (2010) · Oncogene · doi:10.1038/onc.2010.350 · Cited by 105
Fibroblast Hepatocyte Growth Factor Promotes Invasion of Human Mammary Ductal Carcinoma In situ
Jedeszko, C., Victor, B. C., Podgorski, I., & Sloane, B. F. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1043 · Cited by 104
Thalidomide Prevents Bleomycin-Induced Pulmonary Fibrosis in Mice
Tabata, C., Tabata, R., Kadokawa, Y., Hisamori, S., Takahashi, M., Mishima, M., Nakano, T., & Kubo, H. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.1.708 · Cited by 104
Sisson, T. H., Hattori, N., Xu, Y., & Simon, R. H. (1999) · Human Gene Therapy · doi:10.1089/10430349950016960 · Cited by 104
Piccioni, F., Malvicini, M., García, M. G., Rodriguez, A., Atorrasagasti, C., Kippes, N., Buena, I. T. P., Rizzo, M., Bayo, J., Aquino, J. B., et al. (2011) · Glycobiology · doi:10.1093/glycob/cwr158 · Cited by 103
Christensen, L. H., Simonsen, A. C. W., Heegaard, C. W., Moestrup, S. K., Andersen, J. A., & Andreasen, P. A. (1996) · International Journal of Cancer · Cited by 102
ED-B fibronectin as a target for antibody-based cancer treatments
Menrad, A., & Menssen, H. D. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.3.491 · Cited by 102
Rhodes, L. V., Antoon, J. W., Muir, S. E., Elliott, S. G., Beckman, B. S., & Burow, M. E. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-295 · Cited by 102
Loss of SPARC in bladder cancer enhances carcinogenesis and progression
Said, N. A., Frierson, H. F., Sänchez‐Carbayo, M., Brekken, R. A., & Theodorescu, D. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64782 · Cited by 101
Leeming, D. J., Sand, J. M. B., Nielsen, M. J., Genovese, F., Martínez, F. J., Hogaboam, C. M., Han, M. K., Klickstein, L. B., & Karsdal, M. A. (2012) · Biomarker Insights · doi:10.4137/bmi.s9415 · Cited by 100
Means, A. L., Ray, K. C., Singh, A. B., Washington, M. K., Whitehead, R. H., Harris, R. C., Wright, C. V. E., Coffey, R. J., & Leach, S. D. (2003) · Gastroenterology · doi:10.1053/gast.2003.50150 · Cited by 100
Periostin Is Induced in Glomerular Injury and Expressed de Novo in Interstitial Renal Fibrosis
Sen, K., Lindenmeyer, M. T., Gaspert, A., Eichinger, F. H., Neusser, M. A., Kretzler, M., Segerer, S., & Cohen, C. D. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.06.002 · Cited by 99
All- trans -Retinoic Acid Prevents Radiation- or Bleomycin-induced Pulmonary Fibrosis
Tabata, C., Kadokawa, Y., Tabata, R., Takahashi, M., Okoshi, K., Sakai, Y., Mishima, M., & Kubo, H. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200606-862oc · Cited by 99
Antibody-based targeting of the tumor vasculature
Schliemann, C., & Neri, D. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2007.08.002 · Cited by 99
The Chemokine CXCL8 in Carcinogenesis and Drug Response
Gales, D. N., Clark, C. E., Manne, U., & Samuel, T. (2013) · ISRN Oncology · doi:10.1155/2013/859154 · Cited by 99
Baghy, K., Dezső, K., László, V., Fullár, A., Péterfia, B. F., Paku, S., Nagy, P., Schaff, Z., Iozzo, R. V., & Kovalszky, I. (2010) · Laboratory Investigation · doi:10.1038/labinvest.2010.172 · Cited by 98
Huet, E., Vallée, B., Szul, D., Verrecchia, F., Mourah, S., Jester, J. V., Hoang-Xuan, T., Ménashi, S., & GaMson, E. E. (2007) · The FASEB Journal · doi:10.1096/fj.07-8748com · Cited by 98
HUANG, C., Yang, G., Jiang, T., Zhu, G., Li, H., & Qiu, Z. (2011) · Neoplasma · doi:10.4149/neo_2011_05_396 · Cited by 98
Kagan, H. M. (2000) · Acta Tropica · doi:10.1016/s0001-706x(00)00128-5 · Cited by 97
TNF-α neutralization ameliorates obstruction-induced renal fibrosis and dysfunction
Meldrum, K. K., Misseri, R., Metcalfe, P., Dinarello, C. A., Hile, K. L., & Meldrum, D. R. (2006) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00620.2005 · Cited by 97
PAR-1 and Thrombin: The Ties That Bind the Microenvironment to Melanoma Metastasis
Zigler, M., Kamiya, T., Brantley, E. C., Villares, G. J., & Bar‐Eli, M. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1432 · Cited by 97
Inhibition of the Hedgehog Pathway Targets the Tumor-Associated Stroma in Pancreatic Cancer
Hwang, R. F., Moore, T. T., Hattersley, M. M., Scarpitti, M., Yang, B., Devereaux, E., Ramachandran, V., Arumugam, T., Ji, B., Logsdon, C. D., et al. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0022 · Cited by 97
Lung Cancer and Interstitial Lung Diseases: A Systematic Review
Archontogeorgis, K., Steiropoulos, P., Τzouvelekis, Α., Nena, E., & Bouros, D. E. (2012) · Pulmonary Medicine · doi:10.1155/2012/315918 · Cited by 97
Risk of pancreatic cancer in patients with cystic fibrosis: Table 1
Maisonneuve, P., Marshall, B. C., & Lowenfels, A. B. (2007) · Gut · doi:10.1136/gut.2007.125278 · Cited by 96
PPAR gamma, bioactive lipids, and cancer progression
Gregory, T. (2011) · Frontiers in bioscience · doi:10.2741/4021 · Cited by 95
Lim, K. P., Cirillo, N., Hassona, Y. M., Wei, W., Thurlow, J. K., Cheong, S. C., Pitiyage, G. N., Parkinson, E. K., & Prime, S. S. (2010) · The Journal of Pathology · doi:10.1002/path.2841 · Cited by 95
Kim, J. H., Kim, H. Y., Kim, S., Chung, J.-H., Park, W. S., & Chung, D. H. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61211-4 · Cited by 94
The Role of Endothelin-1 in the Pathogenesis of Idiopathic Pulmonary Fibrosis
Swigris, J. J., & Brown, K. K. (2010) · BioDrugs · doi:10.2165/11319550-000000000-00000 · Cited by 94
Galectin-1 Is a Novel Functional Receptor for Tissue Plasminogen Activator in Pancreatic Cancer
Roda, O., Zapater, E. O., Martínez‐Bosch, N., Gallego, R. G., Vila‐Perelló, M., Ampurdanés, C., Gabius, H., André, S., Andreu, D., Real, F. X., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.12.039 · Cited by 94
FAK Regulates Intestinal Epithelial Cell Survival and Proliferation during Mucosal Wound Healing
Owen, K. A., Abshire, M. Y., Tilghman, R. W., Casanova, J. E., & Bouton, A. H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023123 · Cited by 94
Emerging roles of PDGF-D in EMT progression during tumorigenesis
Wu, Q., Hou, X., Xia, J., Qian, X., Miele, L., Sarkar, F. H., & Wang, Z. P. (2012) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2012.11.006 · Cited by 93
CXC-Type Chemokines Promote Myofibroblast Phenoconversion and Prostatic Fibrosis
Gharaee‐Kermani, M., Kasina, S., Moore, B. B., Thomas, D. G., Mehra, R., & Macoska, J. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049278 · Cited by 92
Periostin deposition in the stroma of invasive and intraductal neoplasms of the pancreas
Fukushima, N., Kikuchi, Y., Nishiyama, T., Kudō, A., & Fukayama, M. (2008) · Modern Pathology · doi:10.1038/modpathol.2008.77 · Cited by 92
Clinical Significance of BMP7 in Human Colorectal Cancer
Motoyama, K., Tanaka, F., Kosaka, Y., Mimori, K., Uetake, H., Inoue, H., Sugihara, K., & Mori, M. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-007-9746-4 · Cited by 92
Murata, T., Mizushima, H., Chinen, I., Moribe, H., Yagi, S., Hoffman, R. M., Kimura, T., Yoshino, K., Ueda, Y., Enomoto, T., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0034 · Cited by 92
Tang, L., Liu, K., Wang, J., Wang, C., Zhao, P., & Liu, J. (2010) · Journal of Surgical Oncology · doi:10.1002/jso.21668 · Cited by 91
p16INK4A Represses the paracrine tumor-promoting effects of breast stromal fibroblasts
Al‐Ansari, M. M., Hendrayani, S., Shehata, A. I., & Aboussekhra, A. (2012) · Oncogene · doi:10.1038/onc.2012.270 · Cited by 91
Roles of COX inhibition in pathogenesis of NSAID-induced small intestinal damage
Takeuchi, K., Tanaka, A., Kato, S., Amagase, K., & Satoh, H. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2009.12.026 · Cited by 91
Rönty, M. J., Leivonen, S., Hinz, B., Rachlin, A., Otey, C. A., Kähäri, V., & Carpén, O. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700427 · Cited by 90
TGFβ stimulated re-epithelialisation is regulated by CTGF and Ras/MEK/ERK signalling
Secker, G. A., Shortt, A. J., Sampson, E. M., Schwarz, Q., Schultz, G. S., & Daniels, J. T. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.09.001 · Cited by 90
BMP-7 as antagonist of organ fibrosis
Weiskirchen, R. (2009) · Frontiers in bioscience · doi:10.2741/3583 · Cited by 90
The Function of SPARC as a Mediator of Fibrosis
Trombetta‐eSilva, J., & Bradshaw, A. D. (2012) · The Open Rheumatology Journal · doi:10.2174/1874312901206010146 · Cited by 90
The Mechanical Environment Modulates Intracellular Calcium Oscillation Activities of Myofibroblasts
Godbout, C., Castella, L. F., Smith, E. A., Talele, N. P., Chow, M. L., Garonna, A., & Hinz, B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064560 · Cited by 89
Hardie, W. D., Davidson, C. R., Ikegami, M., Leikauf, G. D., Cras, T. D. L., Prestridge, A. L., Whitsett, J. A., & Korfhagen, T. R. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00020.2008 · Cited by 89
Inhibitors/antagonists of TGF- system in kidney fibrosis
Yanagita, M. (2012) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs381 · Cited by 89
Sobolik, T., Su, Y., Wells, S., Ayers, G. D., Cook, R. S., & Richmond, A. J. (2014) · Molecular Biology of the Cell · doi:10.1091/mbc.e13-07-0360 · Cited by 88
Emerging concepts in pancreatic cancer medicine: targeting the tumor stroma
Neeße, A., Gress, T. M., Tuveson, D. A., Michl, P., & Krug, S. (2013) · OncoTargets and Therapy · doi:10.2147/ott.s38111 · Cited by 87
Howell, D. C. J., Laurent, G. J., & Chambers, R. C. (2001) · Biochemical Society Transactions · doi:10.1042/0300-5127:0300211 · Cited by 87
Yang, F., Strand, D. W., & Rowley, D. R. (2007) · Oncogene · doi:10.1038/sj.onc.1210663 · Cited by 86
Epidermal growth factor receptor inhibits colitis-associated cancer in mice
Dubé, P. E., Yan, F., Punit, S., Girish, N., McElroy, S. J., Washington, M. K., & Polk, D. B. (2012) · Journal of Clinical Investigation · doi:10.1172/jci62888 · Cited by 86
Overexpression of protease‐activated receptors‐1,‐2, and‐4 (PAR‐1, ‐2, and ‐4) in prostate cancer
Black, P. C., Mize, G. J., Karlin, P., et al. (2007) · The Prostate · doi:10.1002/pros.20503 · Cited by 85
Up-regulation of stromal versican expression in advanced stage serous ovarian cancer
Ghosh, S., Albitar, L., LeBaron, R. G., Welch, W. R., Samimi, G., Birrer, M. J., Berkowitz, R. S., & Mok, S. C. (2010) · Gynecologic Oncology · doi:10.1016/j.ygyno.2010.05.029 · Cited by 85
McMenamin, Ú. C., Murray, L., Cantwell, M. M., & Hughes, C. M. (2011) · Cancer Causes & Control · doi:10.1007/s10552-011-9881-x · Cited by 85
Cited by
Fibrosis and cancer: A strained relationship
Piersma, B., Hayward, M.-K., & Weaver, V. M. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188356 · Cited by 680
Immune suppressive mechanisms in the tumor microenvironment
Munn, D. H., & Bronte, V. (2016) · Current Opinion in Immunology · doi:10.1016/j.coi.2015.10.009 · Cited by 519
Design and applications of man-made biomimetic fibrillar hydrogels
Prince, E., & Kumacheva, E. (2019) · Nature Reviews Materials · doi:10.1038/s41578-018-0077-9 · Cited by 379
Biomechanical and biochemical remodeling of stromal extracellular matrix in cancer
Malik, R., Lelkes, P. I., & Cukierman, E. (2015) · Trends in Biotechnology · doi:10.1016/j.tibtech.2015.01.004 · Cited by 348
Self-citationCancer-associated fibroblasts in desmoplastic tumors: emerging role of integrins
Zeltz, C., Primac, I., Erusappan, P., Alam, J., Noel, A., & Gullberg, D. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.08.004 · Cited by 290
Metadata
- Authors
- Rybinski, B., Franco-Barraza, J., & Cukierman, E.
- Venue
- Physiological Genomics
- Publisher
- American Physiological Society
- Published
- 2014-04-01
- Volume
- 46
- Issue
- 7
- Pages
- 223-244
- ISSN
- 1094-8341 (ISSN-L)
- 1531-2267
- OpenAlex
- W2104906501
- Cited by
- 253
- References
- 543
- FWCI
- 13.48
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.